Floatz logo

DEXDOMITOR

Dystonia

Vanderbilt UniversitySmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Dystonia cohort.

Asset / SponsorPhaseRating
Zinc Acetate Dihydrate
Children's University Hospital Cologne, Germany
Phase 2B
Mtr-601
Motric Bio
Phase 1CC

Same molecule, other indications

DEXDOMITOR is also rated in:

Essential TremorDormant
B
Indicative ·
57 / 100
View asset →
Parkinson diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
schizoaffective disorderDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →